September 2010
Blog

September 2010 posts

Swedish Adds Third da Vinci Si HD Robot and Now Has the Fastest Growing, Most Experienced Robotic-Assisted Surgical Program in the Pacific Northwest

Staying Fit to Prevent Stroke

A brisk walk for as little as 30 minutes a day can improve your health in many ways and may reduce your risk for stroke. Join me, and one of our exercise physiologists to learn how to stay fit and reduce your risk for stroke. Free blood pressure screening will also be available.

Cherry Hill - Pinard Foyer

Tuesday, Oct. 12, 11 a.m.-1 p.m

For more information, please contact Sherene Schlegel:

sherene.schlegel@swedish.org

Office: 206-320-3484

Seattle Perinatal Researcher Awarded Two Major NIH Grants

...starts with the first step

 In my first video I talk about why I am doing this and what I hope the outcome will be. Please comment.

FDA Approves First Oral Medication for Multiple Sclerosis

This week the US Food and Drug Administration approved the release of fingolimod (trade name Gilenya®), the first oral medication for the treatment of remitting relapsing multiple sclerosis. Swedish Neuroscience Institute is proud to have participated in the pivotal clinical trial that led to the approval of Gilenya. Gilenya is a welcome addition to the set of medications available to patients living with MS. There are currently five injectable therapies and two intravenous therapies approved by the FDA for the treatment of MS. Although these treatments are very effective, many patients have been hoping for an oral alternative. Some patients are finding that they have “injection fatigue” or are running out of places to inject the medication. It is important to note, however, that not all patients should switch to Gilenya. Patients with stable disease should remain on their medications. Patients need to be informed of the risks associated with Gilenya, including slowed heart rate, increased blood pressure, difficulty breathing, abnormal liver function, and infection, and how these risks may apply to them. If you are wondering whether Gilenya is right for you, please ask your neurologist.

GE Chairman and CEO, Plus 41 Other National Health-Care Experts, to Gather in Seattle Oct. 11-12; National Symposium to Focus on Innovative Ways to Fix Health Care in This Country

Swedish Looking for Artwork from Children, Young Adults to Feature in New Redmond Campus

Results 1-7 of 21